.jpg)
Computer artwork of monoclonal antibodies approaching a cancer cell.
Whether you are creating a diagnostic assay or have specific research goals at some point you will likely need a long term solution to obtaining a homogenous supply of a reliable, well characterized, and reproducible antibody. The traditional solution for meeting this need is the development of a hybridoma that produces a monoclonal antibody.
Our experts have been developing monoclonal antibodies for Pharmaceutical, Biotechnology, Research and Government Agencies for over 20 years and can guide you through the process of developing a custom monoclonal antibody strategy that specifically meets your needs.
SDIX has offers a full suite of custom services to successfully create your monoclonal solution:
- Technical expertise and strategy development
- Custom antigen solutions including peptide, recombinant proteins, and new technologies such our proprietary Genomic Antibody Technology
- Custom Immunization protocols
- Custom Screening strategies
- Various production scales